申请人:Mitsui Petrochemical Industries, Ltd.
公开号:US04734418A1
公开(公告)日:1988-03-29
Disclosed herein is an antihypertensive preparation containing, as an active component, a novel quinazoline derivative represented by the following general formula or a salt thereof: ##STR1## wherein R.sup.100 means a hydrogen atom or methoxy group, R.sup.200 and R.sup.300 denote individually a hydrogen atom or lower alkoxy group, R.sup.400 is a hydrogen atom or amino group, l stands for 2 or 3, and Het is a specific hetero ring group.
本文揭示了一种抗高血压制剂,其包含一种新型喹唑啉衍生物作为活性成分,该衍生物由以下通用公式表示或其盐:其中R.sup.100表示氢原子或甲氧基,R.sup.200和R.sup.300分别表示氢原子或较低的烷氧基,R.sup.400为氢原子或氨基,l代表2或3,Het是特定的杂环基团。